The role of apoptosis in neurodegenerative diseases

Progress in Drug Research

Volumn 48, Issue , 1997, Pages 55-98

  Hajimohamadreza, Iradj ^a   Treherne, J Mark ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AK 295; CALCIUM ION; CALPAIN INHIBITOR 1; CALPASTATIN; CALPEPTIN; CYCLIN DEPENDENT KINASE; CYCLINE; FREE RADICAL; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOSIDE; OLOMOUCINE; PROTEASOME; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; SKF 104351; UNCLASSIFIED DRUG; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; CELL CYCLE; CELL DEATH; DEGENERATIVE DISEASE; DRUG STRUCTURE; HEAD INJURY; HUMAN; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

EID: 0030917695     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8861-5_3     Document Type: Review

References (173)

1. A. Fraser and G.Evan: A license to kill. Cell 85, 781-784 (1996).
2. R.E. Ellis, J. Yuan, H.R. Horvitz: Mechanisms and functions of cell death. Ann. Rev. Cell Biol., 663-698 (1991).
3. A.H. Wyllie, M.J. Arends, R.G. Morris, S.W. Walker and G. Evan: The apoptosis endonuclease and its regulation. Semin. Immunol. 4(6), 389-379 (1992).
4. D.L. Vaux: Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci., USA 90(3), 786-789 (1993).
5. A. H. Wyllie: The genetic regulation of apoptosis. Curr. Opin Genet. Dev. 5(1), 97-104 (1995).
6. D. Hockenbery: Defining apoptosis. Am. J. Pathol. 146(1), 16-19 (1995).
7. S. Kumar: ICE-like proteases in apoptosis. Trends Biochem. Sci. 20(5), 198-202 (1995).
8. D.R. Dowd: Calcium regulation of apoptosis. Adv. Second Messenger Phosphoprotein Res. 30, 255-280 (1995).
9. S. Orrenius: Apoptosis: molecular mechanisms and implications for human disease. J. Intern. Med. 237(6), 529-536 (1995).
10. C.B. Thompson: Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462 (1995).
11. A.C. Lo, L.J. Houenou and R.W. Oppenheim: Apoptosis in the nervous system: morphological features, methods, pathology and prevention. Arch. Histol. Cytol. 58(2), 139-149 (1995).
12. D.E. Bredesen: Neural apoptosis. Ann. Neurol. 38(6), 839-851 (1995).
13. C.W. Cotman and J.A. Anderson: A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45 (1995).
14. P. Spence, R. Franco, A. Wood and J.A. Moyen Mechanisms of apoptosis as drug targets in the central nervous system. Exp. Opin. Ther. Patents 6(4), 345-366 (1996).
15. A. Glüksmann: Cell death in normal vertebrate ontogeny. Biol. Rev. 26, 59-86 (1951).
16. R.A. Lockshin and C.M. Williams: Programmed cell death. II. Endocrine potentiation of the brackdown of the intersegmental muscles of silkmoths. J. Insect Physiol. 10, 643-649 (1964).
17. J.R. Tata: Requirement for RNA and protein synthesis for induced regression of tadpole tail in organ culture. Dev. Biol. 13, 77-94 (1966).
18. J.F.R. Kerr, A.H. Wyllie, A.R. Currie: Apotosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26, 239 (1972).
19. J. Funder: Apoptosis: two p or not two p. Nature 371, 98 (1994); S. Norby: Opting for Silence. Nature 372, 132 (1994).
20. J. Funder: Apoptosis: two p or not two p. Nature 371, 98 (1994); S. Norby: Opting for Silence. Nature 372, 132 (1994).
21. J. Funder: Apoptosis forever. Nature 373, 379 (1994).
22. D. Hockenbery, G. Nunez, C. Milliman et al.: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336 (1990).
23. Y.J. Liu, D.E. Joshua, G.T. Williams et al.: Mechanisms of antigen driven selection in germinal centres. Nature 342, 21-28 (1989).
24. J.C. Ameisen and A. Capron: Cell dysfunction and depletion in AIDS: the program cell death hypothesis. Immunol. Today 12, 102-105 (1991).
25. M.L. Gougeon, R. Oliver, S. Garcia et al.: Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV-infected patients. C. R. Acad. Sci. 312, 529-537 (1991).
26. R.J. Clem, M. Fechheimer and L.K. Miller: Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254, 1388-1390 (1991).
27. P.A. Hershberger, J.A. Dickson and P.D. Friesen: Site-specific mutagenesis of the 35-kilodalton protein gene encoded by Autographa californica nuclear polyhedrosis virus: cell line-specific effects on virus replication. J. Virol. 66, 5525-5533 (1992).
28. J.F.R. Kerr and B.V. Harmon: Definition and incidence of apotosis an historical perspective. In L.D. Tomei and F.O. Cope, eds. Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, Plainview, NY 1991, 5-29.
29. S.V. Lennon, S.J. Martin and T.G. Cotter: Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24, 203-214 (1991).
30. L.D. Tomei, J.P. Shapiro and F.O. Cope: Apoptosis in C3H/10T 1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA. 90, 853-857 (1992).
31. A.H. Wyllie: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556 (1980).
32. D.J. McConkey and S. Orrenius: Cellular signaling in thymocyte apoptosis. In L.D. Tomei and F.O. Cope, eds. Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, Plainview, NY 1991, 227-246.
33. L.D. Tomei: Apoptosis: a program for death or survival? In L.D. Tomei and F.O. Cope, eds. Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, Plainview, NY 1991, 279-316.
34. A. Batistatou and L. A. Greene: Aurintricarboxlyic acid recuses PC-12 cells and sympathetic neurones from cell death caused by nerve growthfactor deprivation: correlation with suppresion of endonuclease activity. J. Cell Biol. 115, 461-471 (1991).
35. M.L. Gaido and J.A. Cidowski. Indentification, purification and characterisation of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. NUC18 is not histone H2B. J. Biol. Chem. 266, 18580-18585 (1991).
36. R.W. Oppenheim: Cell death during the development of the nervous system. Ann. Rev. Neurosci. 14, 453-501 (1991).
37. E. Janec and R.E. Burke: Naturally occuring cell death during postnatal development of the substantia nigra pars compacts of the rat. Molec. Cell Neurosci. 4, 30-35 (1993).
38. A. Macaya, F. Muncll, R.M. Gubits. and R.E. Burke: Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci, USA 91(17), 8117-21 (1994).
39. K.A. Wood, B. Dipasquale and R.J. Youle. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 11(4): 621-632 (1993).
40. C.M. Waters, W. Moser, G. Walkinshaw and I.J. Mitchell. Death of neurons in the neonatal rodent and primate globus pallidus occurs by a mechanism of apoptosis. Neurosci. 63(3): 881-894 (1994).
41. A.G. Estevez, R. Radi, L. Barbeito, J.T. Shin, J.A. Thompson and J.S. Beckman: Peroxynitrite-induced cytotoxcity in PC-12 cells: evidence for an apototic mechanism differentially modulated by neurotrophic factors J. Neurochem. 65, 1543-1550 (1995).
42. Y. Agid: Aging, disease and nerve cell death. Bull. Acad. Natl. Med. 179(6), 1193-203 (1995).
43. I.J. Mitchell, S. Lawson, B. Mose, S.M. Laidlaw, A.J. Cooper, G. Walkinshaw and C.M. Waters: Glutamate-induced apoptosis results in a loss of striatal neurons in the Pakinsonian rat. Neurosci. 63(1), 1-5 (1994).
44. A.M. Janson: Apoptosis-like neuronal death in vivo in the MPTP mouse model of Parkinson's disease. 25th Soc. Neurosci. San Diego. USA 21, 1273 (1995).
45. V. Jackson-Lewis, M.W. Jakowec, R.E. Burke and S. Przedborski: Time course and morphology of MTPT-induced neuronal death. 25th Soc. Neurosci. San Diego, USA 21, 2002 (1995).
46. Y.A. Barde: Trophic factors and neuronal survival. Neuron 2, 1525-1534 (1989).
47. H. Thoenen, F.A. Barde, A.M. Davies and J.E. Johnson: Neurotrophic factors and neuronal death. In: Selective neuronal death. Ciba Found. Symp. 126, 82-95 (1987).
48. R.M. Lindsay: Neuron saving schemes. Nature 373, 289-290 (1995).
49. M. Baringa: Neurotrophic factors enter the clinic. Science 264, 272-274 (1994).
50. G. Walkinshaw and C.M. Waters: Neurotoxin-induced cell death in neuronal PC-12 cells is mediated by induction of apoptosis. Neurosci. 63(4), 975-987 (1994).
51. G. Walkinshaw and C.M. Waters: Induction of apoptosis in catecholeaminergic PC-12 cells by L-DOPA: implications for the treatment of Parkinson's Disease. J. Clin. Invest. 95, 2458-2464 (1995).
52. D.T. Dexter, A, Carayon, M. Vidailhet, M. Rugerb, F. Agid, A.J. Lees, F.R. Wells, P. Jenner and D. Marsden: Decreased ferritin levels in the brain in Parkinson's Disease. J. Neurochem 55, 16-20 (1990).
53. A. Hartley, J.M. Stone, C. Heron, J.M. Cooper, A.H.V. Schapira: Complex inhibitors induce dose-dependent apoptosis in PC-12 cells: relevance to parkinson's disease. J. Neurochem. 63, 1987-1990 (1994).
54. B. Dipasquale, A.M. Marini and R.J. Youle: Apoptosis and DNA degradation induced by MTPT in neurons. Biochem. Biophys. Res. Commun. 181, 1442-1448 (1991).
55. J.H. Su, A.J. Anderson, B.J. Cummings and C.W. Cotman: Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5, 2529-2533 (1994).
56. J.H. Su, A.J. Anderson and C.W. Cotman: Quantitative assessment of apoptotic-like nuclei in hippocampal formation of Alzheimer brain. 25th Soc. Neurosci. San Diego, USA 21, 1727 (1995).
57. M. Dragunow: DNA fragmentation in Alzheimer's disease hippocampus correlation with tau and β-amyloid immunoreactivity. 25th Soc. Neurosci. San Diego, USA 21, 1724 (1995).
58. A.J. Anderson, J.H. Su and C.W. Cotman: DNA damage and apoptosis in Alzheimer's disease: colocalisation with c-JUn immunoreactivity, relationship to brain area and effects of postmortem delay. J. Neurosci. 16(5), 1710-1719 (1996).
59. H. Lassman, C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger and H.M. Wisniewski: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89, 35-41 (1995).
60. L.S. Perlmutter, A.F. Bushnell, Y.-P. Li, S. Webster and S. Wong: Evidence for DNA damage, but not apoptosis, in Alzheimer's diseased brain. 25th Soc. Neurosci. San Diego, USA 21, 1721 (1995).
61. A. Mighelia, P. Cavalla, R Piva, M.T. Giordana and D. Schiffer: Bcl-2 protein expression in aged brain and neurodegenerative diseases. NeuroReport 5, 1906-1908 (1994).
62. T. Satou, B.J. Cummings and C.W. Cotman: Bcl-2 protein immunoreactivity increases in Alzheimer's disease brain with disease severity. 25th Soc. Neurosci. San Diego, USA 21, 1726 (1995).
63. S. O'Barr, J. Schultz, M. McKinley and J. Rogers: Expression of Bcl-2 oncoprotein in Alzheimers disease. 25th Soc. Neurosci. San Diego, USA 21, 740 (1995).
64. E.M. Johnson: Possible role of neuronal apotosis in Alzheimer's disease. Neurobiol. Aging 15(2), S187-S189 (1994).
65. F.M. Laferla, B.T. Tinkle, C.J. Bieberich, C.C. Haudenschild and G. Jay: The Alzheimer's Aβ-peptide-induced neurodegeneration and apoptotic cell death in transgenic mice Nat. Genet. 9, 21-30 (1995).
66. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525 (1996).
67. G. Forloni, R. Chiesa, S. Smiroldo, L. Verga, M. Salmona, F. Tagliavini and N. Angeretti: Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35. NeuroReport 4, 523-526 (1993).
68. D.T. Loo, A. Copani, C.J. Pike, R.R. Whittemore, A.J. Walencewicz and C.W. Cotman: Apoptosis is induced by β-amyloid in cultures central nervous system neurons. Proc. Natl. Acad. Sci. USA 4, 523-526 (1993).
69. C. Behl, J.B. Davis, F.G. Klier and D. Schubert: Amyloid β-peptide induces necrosis rather than apoptosis. Brain Res. 645, 253-264 (1994).
70. M. Gschwind and G. Huber: Apoptotic cell death induced by β-amyloid peptide is cell type dependent. J. Neurochem. 65(1), 292-300 (1995).
71. J.W. Kuisak, S.S. Sisodia and B. Zhao: Apoptosis is induced by expression of mutant amyloid precursor protein in neuronal cells. In: neurodegenerative disorders: common molecular mechanisms, the decade of the brain. Rios, Jamaica 1995; IX: Apoptosis and neurodegenerative disorders.
72. D.W. Choi: Cerebral hypoxia: some new approaches and unanswered questions. J. Neurosci. 10, 2493-2501 (1990).
73. J.T. Coyle and P. Puttfarcken: Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-695 (1993).
74. N.R. Sims and E. Zaidan: Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. Int. J. Biochem. Cell Biol, 27(6), 531-550 (1995).
75. M.D. Linnik, R.H. Zobrist and M.D. Hattield: Evidence supporting a role for programmed cell death in focal cerebral ischaemia in rats. Stroke 24, 2002-2009 (1993).
76. J.M. MacManus, A.M. Buchan, I.E. Hill, I. Rasquinha and E. Preston: Global iscaemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164(1-2), 89-92 (1993).
77. M. Okamoto, M. Matsumoto, T. Ontsuki, A. Taguichi, K. Mikoshita, T. Yanagihara and T. Kamada: Internucleosomal DNA cleavage involved in ischaemia-induced neuronal death. Biochem. Biophys. Res. Commun 196(3), 1356-1362 (1993).
78. E.M. Johnson, L.J.S. Greenlund, P.T. Akins and C.Y. Hsu: Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischaemic brain injury. J. Neurotrauma 12(5), 843-852 (1995).
79. S. Kure, T. Tominaga, T. Yoshimoto, K. Tada and K. Narisawa: Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179(1), 39-45 (1991).
80. F. Dessi, C. Charriaut-Marlangue, M. Khrestchatisky, Y. Ben-Ari: Glutamate-induced neuronal death is not a programmed cell death in cerebellar cultures. J. Neurochem. 60(5), 1953-1955 (1993).
81. D.W. Choi, K. Koh, J.A. Demaro, H.S. Ying, M.F. Jaquin and V.J. Gwag: Even slowlytriggered neuronal death of cultured cortical neurons occurs by necrosis not apoptosis. 25th Soc. Neurosci. San Diego, USA 21, 1585 (1995).
82. M. Ankarcrona, J.M. Dypbukt, E. Bonfoco, B. Zhivotovsky, S. Orrenius, S.A. Lipton and P. Nicotera: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 (4), 961-973 (1995).
83. B.J. Gwag, D. Lohner, J.Y. Koh, M.B. Wie and D.W. Choi: Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neurosci. 68(3), 615-619 (1995).
84. A. Copani, V.M.G. Bruno, V. Barresi, G. Battaglia, D.F. Condorelli and F. Nicoletti: Activation of metabatropic glutamate receptors prevents neuronal apotosis in culture. J. Neurochem. 64(1), 101-108 (1995).
85. J.Y. Koh, E. Palmer and C.W. Cotman: Activation of the metabotropic glutamate receptor attenuates NMDA neurotoxicity in cortical cultures. Proc. Natl Acad. Sci. USA 88, 9431-9435 (1991).
86. R.F. Regan and D.W. Choi: Excitotoxicity and central nervous system trauma. In: The Neurobiology of Central Nervous System Trauma. S.D. Salzman and A.L. (Eds.) Oxford University Press, New York 1994, 173-181.
87. T.K. McIntosh, R. Vink, L. Noble, I. Yamakami. S. Fernyak, H. Soaresand L.H. Faden: Traumatic brain injury in the rat: characterisation of a lateral fluid-percussion model. Neurosci. 28, 233-244 (1989).
88. A. Rink, K.M. Fung, J.Q. Trojanowski, V.M.-Y. Lee, E. Neugebauer and T.K. McIntosh: Evidence of apototic cell death after experimental traumatic brain injury in the rat. Am J. Pathol. 147(6), 1575-1583 (1995).
89. A. Conti, C.M. Hylton, R. Raghupathi, D.H. Smith, J.Q. Trojanowski, V.M.-Y. Lee and T.K. McIntosh: Magnesium deficiency decreases the occurrence of apoptosis after traumatic brain injury. 13th Annual Neurotrauma Symposium. San Diego, USA 1995.
90. G. Sinson, B. Perri, J.Q. Trojanowski, V.M.-Y. Lee and T.K. McIntosh: Apoptotic death in the septal nuclei after fluid percussion brain injury is attenuated by NGF infusion. 13th Annual Neurotrauma Symposium. San Diego, USA 1995.
91. W.I. McDonald and D.H. Silbergerg: Multiple sclerosis Butterworths, London, 1986.
92. M. Dubois-Dalq and R. Armstrong: The cellular and molecular events of the central neurons remyelination. Bioessay 12, 569-576 (1990).
93. B.A. Barres, I.K. Hart, H.S.R. Coles, J.F. Burne, J.T. Voyvodic, W.D. Richardson and M.C. Raff: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46 (1992).
94. P.E. Knapp, R.P. Skoff and W.R. Redstone: Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit. J. Neurosci. 6(10), 2813-2822 (1986).
95. M.P. Pender, K.B. Nguyen, P.A. McCombe, and J.F.R. Kerr: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurosci. 104, 81-87 (1991).
96. K. Selmaj, C.S. Raine, M. Farooq, W.T. Norton and C.F. Brosnan: Cytokine toxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147(5), 1522-1529 (1991).
97. S. Prabhakar, S. D'Souza, J.P. Antel, J.A. McLaurin, H.M. Schipper and E. Wang: Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res. 195 672, 159-169 (1995).
98. D. Muir and D.A.S. Compston: Growth factor stimulation triggers apoptotic cell death in mature rat oligodendrocytes. J. Neurosci. Res. 44 (1), 1-11 (1996).
99. N.J. Scolding and W.A.J. Houston, C. Linington, B.P. Morgan, A.K. Campbell and D.A.S. Compston: Oligodendrocytes activate complement but recover by vesicular removal of membrane attack complexes. Nature 338, 620-622 (1989).
100. D.R. Wren and M. Noble: Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptable to the lytic effects of complement in the absence of antibody. Proc. Natl Acad. Sci. USA 86, 9025-9029 (1989).
101. A. Wood, M. Wing, C.D. Benham and D.A.S. Compston: Specific induction of intracellular oscillations by complement membrane attack on oligodendroglia. J. Neurosci. 13, 3319-3332 (1993).
102. Z. Tabi, P.A. McCombe and M.P. Pender: Apoptotic elimation of V beta 8.2+ cells-from the central nervous system during recovery from EAE induced by the massive transfer of V beta 8.2 encepalitogenic T cells. Eur. J. Immunol. 24(11), 2609-2617 (1994).
103. C.M. Pelfrey, L.R. Tranquill, S.A. Boehme, H.F. McFarland and M.J. Lenardo: Two mechanisms of antigen-specific apoptosis of myelin basic protein-specific T-lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154 (11), 6191-6202 (1995).
104. X. Mu, J. He, D.W. Anderson, J.Q. Trojanowski and J.E. Springer: Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis motoneurons. 25th Soc. Neurosci. San Diego, USA 21, 561 (1995).
105. M. Dubois-Dauphin, H. Frankowski, Y. Tsujimoto, J. Huarte and J.C. Martinou: Neonatal motoneurons overexpressing the bcl-2 proto-oncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl Acad. Sci. USA 91, 229-240 (1994).
106. C.M. Troy and M.E. Shelanski: Down regulation of copper/zinc superoxide dismutase causes apoptotic death in PC-12 neuronal cells. Proc. Acad. Natl Sci. USA 91, 6384-6387 (1994).
107. E.S. Greenlund, T.E. Deckwerth, E.M. Johnson: Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315 (1995).
108. J.D. Rothstein, E.A. Bristol, B. Hosler, R.H. Brown and R.W. Kuncl: Chronic inhibiton of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91, 4155-4159 (1994).
109. S. Rabizadeh, E.B. Grallaeb, D.R. Borchelt, R. Gwinn, J.S. Valentine, S. Sisodia, P. Wong, M. Eee, H. Hahn and D.E. Bredesen: Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a pro-apoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92, 3024-3028 (1995).
110. J. Busciglio and B.A. Yankner: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779 (1995).
111. P.J. Lucassen, A. Williams, W.C. Chung and H. Fraser: Dectection of apoptosis in murine scrapie. Neurosci. Lett. 198(3), 185-188 (1995).
112. A. Giese, M.H. Groschup, B. Hess and H.A. Kretzschmar: Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol. 5(3), 213-221 (1995).
113. C. Portera-Cailliau, J.C. Hedreen, D.E. Price and V.E. Koliatos: Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15(5), 3775-3787 (1995).
114. Y. A. Lazebnik, S.H. Kaufmann, S. Desnoyers, G.G. Poirier, and W.C. Earnshaw: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371, 346-7 (1994).
115. L.A. Casciola-Rosen, D.K. Miller, G.J. Anhalt, and A. Rosen: Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269, 30757-60 (1994).
116. S.J. Martin, G.A. O'Brien, W.K. Nishioka, A.J. McGahon, A. Mahboubi, T.C. Saido, and D.R. Green: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 270, 6425-8 (1995).
117. M.J. Smyth and J.A. Trapani: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today. 16, 202-6 (1995).
118. S. Kumar and N.L. Harvey: Role of multiple cellular proteases in the execution of programmed cell death. Febs Lett. 375, 169-73 (1995).
119. M. Miura, H. Zhu, R. Rotello, E.A. Hartwieg, and J. Yuan: Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75, 653-60 (1993).
120. V. Gagliardini, P.A. Fernandez, R.K. Lee, H.C. Drexler, R.J. Rotello, M.C. Fishman, and J. Yuan: Prevention of vertebrate neuronal death by the crm A gene [see comments] [published erratum appears in Science 1994 Jun 3264(5164):1388]. Science. 263, 826-8 (1994).
121. I. Martinou, P.A. Fernandez, M. Missotten, E. White, B. Allet, R. Sadoul, and J.C. Martinou: Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol. 128, 201-8 (1995).
122. P.A. Henkart: ICE family proteases: mediators of all apoptotic cell death? Immunity. 4, 195-201 (1996).
123. A. Fraser and G. Evan: A license to kill. Cell 85, 781-4 (1996).
124. M.K. Squier, A.C. Miller, A.M. Malkinson, and J.J. Cohen: Calpain activation in apoptosis. J Cell Physiol. 159, 229-37 (1994).
125. K.K. Wang and P.W. Yuen: Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci. 15, 412-9 (1994).
126. J.M. Peters: Proteasomes: protein degradation machines of the cell.Trends Biochem Sci. 19, 377-82 (1994).
127. A.L. Goldberg: ATP-dependent proteases in prokaryotic and eukaryotic cells. Semin Cell Biol. 1, 423-32 (1990).
128. M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del-Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [see comments]. Science. 269, 682-5 (1995).
129. S.J. Martin and D.R. Green: Apoptosis during HIV infection. A cytopathic effect of HIV or an important host-defense mechanism against viruses in general? Adv Exp Med Biol. 374, 129-38 (1995).
130. G.J. Lees:The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci. 114, 119-22 (1993).
131. T. Morioka, A.N. Kalehua, and W.J. Streit: Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol. 327, 123-32 (1993).
132. J. Gehrmann, R. Gold, C. Linington, J. Lannes-Vieira, H. Wekerle, and G.W. Kreutzberg: Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation. Lab Invest. 67, 100-13 (1992).
133. D. Giulian, M. Corpuz, S. Chapman, M. Mansouri, and C. Robertson: Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res. 36, 681-93 (1993).
134. D. Giulian and C. Robertson: Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol. 27, 33-42 (1990).
135. R.A. Lang and J.M. Bishop: Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell. 74, 453-62 (1993).
136. E.J. Beilharz, C.E. Williams, M. Dragunow, E.S. Sirimanne, and P.D.Gluckman: Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res. 29, 1-14 (1995).
137. B.A. Barres, R. Schmid, M. Sendnter, and M.C. Raff: Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-95 (1993).
138. J. Guan, C. Williams, M. Gunning, C. Mallard, and P. Gluckman: The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb Blood Flow Metab. 13, 609-16 (1993).
139. M. Oren: Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol. 5, 221-7 (1994).
140. S. Sakhi, A. Bruce, N. Sun, G. Tocco, M. Baudry, and S.S. Schreiber: p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 91, 7525-9 (1994).
141. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C. Montgomery Jr., J.S. Butel, and A. Bradley: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-21 (1992).
142. S.F. Dowdy, P.W. Hinds, K. Louie, S.I. Reed, A. Arnold, and R.A. Weinberg: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73, 499-511 (1993).
143. V. Baldin, J. Lukas, M.J. Marcote, M. Pagano, and G. Draetta: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-21 (1993).
144. R.S. Freeman, S. Estus, and E. Johnson Jr.: Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 12, 343-55 (1994).
145. O. Kranenburg, A.J. van-der-Eb, and A. Zantema: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. Embo J. 15, 46-54 (1996).
146. K. Herrup and J.C. Busser: The induction of multiple cell cycle events precedes target-related neuronal death. Development 121, 2385-95 (1995).
147. K. Ando, F. Ajchenbaum-Cymbalista, and J.D. Griffin: Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci USA 90, 9571-5 (1993).
148. T. Shimizu, P.M. O'Connor, K.W. Kohn, and Y. Pommier: Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55, 228-31 (1995).
149. S.C. Chen, T. Curran, and J.I. Morgan: Apoptosis in the nervous system: new revelations. J Clin Pathol. 48, 7-12 (1995).
150. Y. Gazitt and G.W. Erdos: Fluctuations and ultrastruclural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. Cancer Res. 54, 950-6 (1994).
151. L.H. Tsai, I. Delalle, V. Caviness Jr., T. Chae, and E. Harlow: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-23 (1994).
152. D. Tang, J. Yeung, K. Y. Lee, M. Matsushita, H. Matsui, K. Tomizawa, O. Hatase, and J.H. Wang: An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem. 270, 26897-903 (1995).
153. J. Ham, C. Babij, J. Whitfield, C.M. Pfarr, D. Lallemand, M. Yaniv, and L.L. Rubin: A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-39 (1995).
154. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-31 (1995).
155. Z.N. Oltvai and S.J. Korsmeyer: Checkpoints of dueling dimers foil death wishes [comment]. Cell 79, 189-92 (1994).
156. G.A. Silverman, E. Yang, J.H. Proffitt, M. Zutter, and S.J. Korsmeyer: Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes. Mol Cell Biol. 13, 5469-78 (1993).
157. C.M. Knudson, K.S. Tung, W.G. Tourtellotte, G.A. Brown, and S.J. Korsmeyer: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-9 (1995).
158. E.H. Cheng, B. Levine, L.H. Boise, C.B. Thompson, and J.M. Hardwick: Bax-independent inhibition of apoptosis by Bel-XL. Nature 379, 554-6 (1996).
159. H. Frankowski, M. Missotten, P.A. Fernandez, I. Martinou, P. Michel, R. Sadoul, and J.C. Martinou: Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 6, 1917-21 (1995).
160. N. Motoyama, F. Wang, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, et al.: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-10 (1995).
161. D.J. Veis, C.M. Sorenson, J.R. Shutter, and S.J. Korsmeyer: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-40 (1993).
162. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer: Bad, a heterodimeric partner lor Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-91 (1995).
163. S. Krajewski, S. Bodrug, M. Krajewska, A. Shabaik, R. Gascoyne, K. Berean, and J.C. Reed: Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 146, 1309-19 (1995).
164. S.P. Jaw, D.D. Su, and D.D. Truong: Expression of Bcl-2 and Bax in the frontoparietal cortex of the rat following cardiac arrest. Brain Res Bull. 38, 577-80 (1995).
165. M.P. Mattson, S.W. Barger, J.G. Begley, and R.J. Mark: Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216 (1995).
166. D.W. Choi: Calcium, still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18, 58-60 (1995).
167. D.D. Friel and R.W. Tsien: An FCCP-sensitive Ca2+ store in bullfrog sympathetic-neurons and its participation in stimulus-evoked changes in [Ca2+]i. J Neurosci. 14. 4007-24 (1994).
168. C. Giulivi, A. Boveris, and E. Cadenas: Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA. Arch Biochem Biophys. 316, 909-16 (1995).
169. R.F. Castilho, A.J. Kowaltowski, A.R. Meinicke, and A.E. Vercesi: Oxidative damage of mitochondria induced by Fe(II)citrate or t-butyl hydroperoxide in the presence of Ca2+: effect of coenzyme Q redox state. Free Radic Biol Med. 18, 55-9 (1995).
170. L.L. Dugan, V.M. Bruno, S.M. Amagasu, and R.G. Giffard: Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci. 15, 4545-55 (1995).
171. I.J. Reynolds and T.G. Hastings: Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci. 15, 3318-27 (1995).
172. M.A. Ator and R.E. Dolle: Interleukin-1β converting enzyme: biology and chemistry of inhibitors. Curr. Pharmaceutical Design 1, 191-210 (1995).
173. J. Rotonda, D.W. Nicholson, K.M. Fazil, M. Gallant, Y. Gareau, M. Labelle, E.P. Peterson et al.: The three-dimensional structure of apopain/CPP-32, a key mediator of apoptosis. Nat. Struct. Biol. 3(7), 619-625 (1996).